Overview

A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of repeat oral dosing of ASP1941 on electrocardiogram (ECG) measurements.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination